These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8255960)

  • 1. Campylobacter jejuni and Guillain-Barré syndrome.
    Rees JH; Gregson NA; Griffiths PL; Hughes RA
    Q J Med; 1993 Oct; 86(10):623-34. PubMed ID: 8255960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Five cases of Campylobacter jejuni enteritis accompanied with Guillain-Barré syndrome].
    Yuan JM; Tang J; Hao HJ
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):375-7. PubMed ID: 8269767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome.
    Mishu B; Ilyas AA; Koski CL; Vriesendorp F; Cook SD; Mithen FA; Blaser MJ
    Ann Intern Med; 1993 Jun; 118(12):947-53. PubMed ID: 8489109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serological study of Campylobacter jejuni infections in patients with Guillain-Barré syndrome].
    Takahashi M; Saitoh K; Ohta K; Kudoh Y
    Kansenshogaku Zasshi; 1994 Apr; 68(4):467-73. PubMed ID: 8027593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody level against GroEL type heat-shock protein of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Fujimoto S; Fujita M
    Microbiol Immunol; 1999; 43(3):241-4. PubMed ID: 10338193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome.
    Allos BM
    Infect Dis Clin North Am; 1998 Mar; 12(1):173-84. PubMed ID: 9494837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.
    Mishu B; Blaser MJ
    Clin Infect Dis; 1993 Jul; 17(1):104-8. PubMed ID: 8353228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.